Home Cart 0 Sign in  
X

[ CAS No. 33311-29-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 33311-29-4
Chemical Structure| 33311-29-4
Chemical Structure| 33311-29-4
Structure of 33311-29-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 33311-29-4 ]

Related Doc. of [ 33311-29-4 ]

Alternatived Products of [ 33311-29-4 ]

Product Details of [ 33311-29-4 ]

CAS No. :33311-29-4 MDL No. :MFCD03004838
Formula : C9H13NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :DIOBEQCFVVJJBU-UHFFFAOYSA-N
M.W : 167.21 Pubchem ID :3879885
Synonyms :

Calculated chemistry of [ 33311-29-4 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 4
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 48.04
TPSA : 44.48 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.57 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.91
Log Po/w (XLOGP3) : 1.05
Log Po/w (WLOGP) : 1.3
Log Po/w (MLOGP) : 0.92
Log Po/w (SILICOS-IT) : 1.3
Consensus Log Po/w : 1.3

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.64
Solubility : 3.79 mg/ml ; 0.0227 mol/l
Class : Very soluble
Log S (Ali) : -1.57
Solubility : 4.45 mg/ml ; 0.0266 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.71
Solubility : 0.328 mg/ml ; 0.00196 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.5

Safety of [ 33311-29-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 33311-29-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 33311-29-4 ]
  • Downstream synthetic route of [ 33311-29-4 ]

[ 33311-29-4 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 33311-29-4 ]
  • [ 350-46-9 ]
  • [ 22483-40-5 ]
Reference: [1] Patent: US5880130, 1999, A,
  • 2
  • [ 22483-40-5 ]
  • [ 33311-29-4 ]
YieldReaction ConditionsOperation in experiment
98% With palladium 10% on activated carbon; hydrogen; acetic acid In methanol at 20℃; for 10 h; To a solution of 13 (2.06 g, 10.5 mmol) and AcOH (1.25 g, 20.9 mmol) in MeOH (100mL) was added 10percent Pd/C (100 mg) and the mixture was stirred at rt under H2atmosphere (H2 balloon) for 10 h. The solution was filtered through alayer of Celite and the filtrate was concentrated in vacuo to provide compound 14 as a brown oil (1.72 g, 98percent). 1HNMR (600 MHz, CDCl3) δ 6.77 (d, J= 8.9 Hz, 2H), 6.63 (d, J = 8.9 Hz,2H), 4.06-4.03 (m, 2H), 3.72-3.70 (m, 2H), 3.44 (s, 3H), 3.42 (br s, 2H). HRMS(ESI+) calcd for C9H14NO2 (M+H)+168.1019, found 168.1019.
95.7% With palladium 10% on activated carbon; hydrogen In methanol at 20℃; for 16 h; 1- (2-methoxyethoxy) -4-nitrobenzene (1.97 g, 10 mmol)Was added to 50 mL of a methanol solution,10percent Pd / C197 mg was added,The reaction was carried out at room temperature for 16 h.The solid was removed by suction filtration,The filtrate was concentrated to give 1.6 g of a pale red oil,Yield 95.7percent.
94.34% With palladium on activated charcoal; hydrogen In methanol at 20℃; for 2 h; Inert atmosphere Synthesis of compound 130.3. To a suspension of Pd/C (0.200g,) in MeOH (20ml) was added compound 130.2 (1.5g, 7.61mmol, l .Oeq) under nitrogen atmosphere. Reaction mixture was purged with H2 (gas) at room temperature for 2 hours. After completion of the reaction, mixture was filtered through celite. Solvent was removed under reduced pressureto afford compound 130.3 (1.2g, 94.34percent). MS (ES): m/z 167.2 [M+H]+.
93% With palladium 10% on activated carbon; hydrogen In methanol at 20℃; [00547] 1-(2-methoxyethoxy)-4-nitrobenzene (38) (3.9 g, 20 mmol), MeOH (80 mL), and 10percentPd on activated carbon ( 400 mg) were charged in a hydrogenation vessel and the reactionmixture was stirred at rt overnight under H2 atmosphere. The mixture was filtered through thecelite. The filtrate was concentrated in vacuo to afford 4-(2-methoxyethoxy)aniline (39) (3.1 g,93percent) as a black oil. LC-MS (ESI): m/z (M+1) 168.1.
56.7% With iron; ammonium chloride In tetrahydrofuran; water for 4 h; Reflux To a solution of compound 3 (25 g, 127 mmol) inTHF (180 mL), water (60 mL) was added. After stirred for ~ 5 min, NH4Cl (28 g, 523 mmol) and Fe (36 g, 635 mmol) were sequentially added. The reaction mixture was heated to refluxing and stirred for 4h. After cooled to room temperature, the mixture was filtered through Celite® and washed with ethyl acetate (200 mL). The filtrate was concentrated under reduced pressure. The crude was re- dissolved in ethyl acetate (500 mL), washed with saturated NaHCO3 (200 mL) and water (200 mL). The organic layer was concentrated under reduced pressure. The crude was further purified by flash column chromatography to yield the desired product 4 (12 g, 56.7percent yield, M+H+= 168.5).
700 mg With palladium on activated charcoal; hydrogen In methanol at 20℃; for 3 h; Compound 115 (lg, 5.08 mmol) was hydrogenated with 100 mg of Pd/C in 20mL of methanol under a hydrogen atmosphere for 3h. The reaction mixture was filtrated on Celite, washed with 20mL of methanol and concentrated under vacuum to yield 700 mg of the pure aniline 116. Light brown oil. Yield = 68percent.

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 21, p. 5177 - 5181
[2] Patent: CN103864792, 2017, B, . Location in patent: Paragraph 0313; 0314; 0315; 0316
[3] Patent: WO2015/131080, 2015, A1, . Location in patent: Paragraph 00768; 00770
[4] Patent: WO2014/130693, 2014, A1, . Location in patent: Paragraph 00544; 00547
[5] European Journal of Medicinal Chemistry, 1980, vol. 15, # 5, p. 399 - 404
[6] Patent: WO2015/6754, 2015, A2, . Location in patent: Paragraph 00243; 00245
[7] Collection of Czechoslovak Chemical Communications, 1971, vol. 36, p. 2527 - 2539
[8] Patent: US2005/277668, 2005, A1, . Location in patent: Page/Page column 17
[9] Patent: WO2017/4543, 2017, A1, . Location in patent: Page/Page column 67
[10] Patent: WO2017/102014, 2017, A1, . Location in patent: Page/Page column 24
  • 3
  • [ 109-86-4 ]
  • [ 540-37-4 ]
  • [ 33311-29-4 ]
YieldReaction ConditionsOperation in experiment
5.3% With caesium carbonate In toluene at 110℃; EXAMPLE 40; 4-(6,7-Dimethoxy-quinazolin-4-yl)-piperidine-1-carboxylic acid [4-(2-methoxy-ethoxy)-phenyl]-amide; a. 4-(2-Methoxy-ethoxy)-phenylamine; A mixture of 4-iodoaniline (219 mg, 1.0 mmol), 2-methoxyethanol (152 mg, 2.0 mmol), copper iodide (19.0 mg, 0.1 mmol), cesium carbonate (554 mg, 1.7 mmol) and 1,10-phenanthroline (36.0 mg, 0.2 mmol) was stirred in toluene (0.5 mL) at 110° C. overnight. The reaction was then cooled to RT and filtered through silica gel and washed with diethyl ether. The ether was removed in vacuo to obtain a crude solid. Purification by prep tlc (1:9 MeOH/DCM) afforded the title compound as a solid (8.9 mg, 5.3percent). 1H NMR (300 MHz, CDCl3) δ 6.82-6.72 (m, 4H), 4.06 (t, 2H), 3.72 (t, 2H), 3.45 (s, 3H).
Reference: [1] Patent: US2006/281772, 2006, A1, . Location in patent: Page/Page column 72
  • 4
  • [ 627-42-9 ]
  • [ 123-30-8 ]
  • [ 33311-29-4 ]
YieldReaction ConditionsOperation in experiment
16% With potassium carbonate In N,N-dimethyl-formamide at 80℃; 4-Aminophenol (2.2 g, 19.8 mmol) and potassium carbonate (5.5 g, 39.6 mmol) were dissolved in DMF. To the reaction mixture was added 1 -chloro-2-methoxyethane (2 ml, 21.8 mmol) and the mixture was stirred overnight at 80 0C. The resulting solids were filtered and the filtrate was washed with brine, dried over Na2SO4, concentrated under reduced pressure, and purified by an ISCO system (50 -100 percent EtOAc in hexanes) to afford 538 mg of the desired product (16 percent yield); m/z 168.
Reference: [1] Patent: WO2008/20203, 2008, A1, . Location in patent: Page/Page column 81
[2] Journal of Medicinal Chemistry, 2013, vol. 56, # 5, p. 1996 - 2015
  • 5
  • [ 350-46-9 ]
  • [ 33311-29-4 ]
Reference: [1] Patent: WO2015/131080, 2015, A1,
[2] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 21, p. 5177 - 5181
[3] Patent: WO2017/102014, 2017, A1,
  • 6
  • [ 100-02-7 ]
  • [ 33311-29-4 ]
Reference: [1] Patent: WO2014/130693, 2014, A1,
[2] Patent: WO2015/6754, 2015, A2,
  • 7
  • [ 110969-99-8 ]
  • [ 33311-29-4 ]
Reference: [1] Yakugaku Zasshi, 1952, vol. 72, p. 521[2] Chem.Abstr., 1952, p. 8810
  • 8
  • [ 1202759-89-4 ]
  • [ 33311-29-4 ]
  • [ 1202759-91-8 ]
  • [ 1202759-90-7 ]
YieldReaction ConditionsOperation in experiment
0.55 g With acetic acid In tert-Amyl alcohol for 4 h; Reflux tert-Butyl (3-((2-chloro-5-fluoropyrimidin-4-yl)amino)phenyl)carbamate (800 mg, 2.37 mmoL) and 4-(2-methoxyethoxy)aniline (576 mg, 2.84 mmoL) were suspended in tert-amyl alcohol (14 mL) and acetic acid (5 drops).
Heated to reflux for 4 h.
After cooling, solvent was removed via rotary evaporation.
The dark oil was partitioned between water/brine and THF (10 mL each), agitated, and separated layers and dried organic phase over sodium sulfate.
The solvent was removed via rotary evaporation to afford a purple solid, 0.55 g. LC/MS (RT=2.997/(M+1)) 470.2.
Additional 150 mg of product minus the (BOC) protecting group crystallized from the aqueous layer
Reference: [1] Patent: US2015/174128, 2015, A1, . Location in patent: Paragraph 0715
  • 9
  • [ 33311-29-4 ]
  • [ 1202759-91-8 ]
Reference: [1] Patent: US2014/179720, 2014, A1,
[2] Patent: US2015/174128, 2015, A1,
  • 10
  • [ 33311-29-4 ]
  • [ 1202757-89-8 ]
Reference: [1] Patent: US2014/179720, 2014, A1,
[2] Patent: US2015/174128, 2015, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 33311-29-4 ]

Aryls

Chemical Structure| 31465-36-8

[ 31465-36-8 ]

4-(4-Methoxyphenoxy)aniline

Similarity: 0.95

Chemical Structure| 4344-55-2

[ 4344-55-2 ]

4-Butoxyaniline

Similarity: 0.92

Chemical Structure| 7664-66-6

[ 7664-66-6 ]

4-Isopropoxyaniline

Similarity: 0.92

Chemical Structure| 15268-07-2

[ 15268-07-2 ]

3,3'-Oxydianiline

Similarity: 0.92

Chemical Structure| 6245-50-7

[ 6245-50-7 ]

4,4'-(Butane-1,4-diylbis(oxy))dianiline

Similarity: 0.92

Ethers

Chemical Structure| 31465-36-8

[ 31465-36-8 ]

4-(4-Methoxyphenoxy)aniline

Similarity: 0.95

Chemical Structure| 4344-55-2

[ 4344-55-2 ]

4-Butoxyaniline

Similarity: 0.92

Chemical Structure| 7664-66-6

[ 7664-66-6 ]

4-Isopropoxyaniline

Similarity: 0.92

Chemical Structure| 15268-07-2

[ 15268-07-2 ]

3,3'-Oxydianiline

Similarity: 0.92

Chemical Structure| 6245-50-7

[ 6245-50-7 ]

4,4'-(Butane-1,4-diylbis(oxy))dianiline

Similarity: 0.92

Amines

Chemical Structure| 31465-36-8

[ 31465-36-8 ]

4-(4-Methoxyphenoxy)aniline

Similarity: 0.95

Chemical Structure| 22013-33-8

[ 22013-33-8 ]

2,3-Dihydrobenzo[b][1,4]dioxin-6-amine

Similarity: 0.93

Chemical Structure| 7664-66-6

[ 7664-66-6 ]

4-Isopropoxyaniline

Similarity: 0.92

Chemical Structure| 15268-07-2

[ 15268-07-2 ]

3,3'-Oxydianiline

Similarity: 0.92

Chemical Structure| 6245-50-7

[ 6245-50-7 ]

4,4'-(Butane-1,4-diylbis(oxy))dianiline

Similarity: 0.92